Correlates of microalbuminuria in hypertensive patients of a tertiary care teaching hospital of Central India


  • Praveen Kumar Tagore Department of Medicine, Gaja Raja Medical College, Gwalior, Madhya Pradesh
  • Archana Gupta Department of Medicine, Gaja Raja Medical College, Gwalior, Madhya Pradesh
  • Dewesh Kumar Department of Community Medicine and Family Medicine, AIIMS Jodhpur, Rajasthan
  • Moorat Singh Yadav Department of Medicine, Gaja Raja Medical College, Gwalior, Madhya Pradesh



Essential hypertension, Micro-albuminuria, Target organ damage, Cardiovascular risk factors


Background: Although the prevalence of hypertension is high in India, the relationship between micro-albuminuria and target organ damage in hypertension is not well studied. Hence this study aims to study the prevalence of micro-albuminuria in patients of hypertension and its correlation with other cardiovascular risk factors.

Methods: This cross-sectional study was done in 112 essential hypertension non-diabetic patients presented at a tertiary care hospital of Madhya Pradesh, India who fulfilled inclusion criteria and exclusion criteria during a calendar year. The diagnosis of essential hypertension was made by the study physician after complete medical history, physical examination and routine biochemical analysis of blood and urine. The data was analysed using SPSS version 20 and Mann Whitney U and Chi-square test was used for quantitative and qualitative data respectively.

Results: The total number of patients having micro-albuminuria was 26 and the prevalence came out to be 23.21%. The mean age of micro-albuminuric patients was less compared to non-microalbuminuric patients (p<0.05). The systolic, diastolic blood pressure and cholesterol levels were found to be higher but was statistically insignificant whereas body mass index (BMI) and duration of disease was statistically  higher (p<0.05) amongst the cases having micro-albumin in their urine.

Conclusions: The prevalence of micro-albuminuria increases with the increase in duration, stages /severity of hypertension. Micro-albuminuria may be considered as a marker of adverse cardiovascular risk profile such as LVH and hyperlipidemia. High BMI, smoking and advanced stages of retinopathy are also the risk factors of micro-albuminuria.



Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol. 1997,80:164-9.

Basi S, Fesler P, Mimran A, Lewis JB. Micro-albuminuria in Type 2 Diabetes and Hypertension. A marker, treatment target, or innocent bystander? Diabetes Care. 2008;31Suppl2:S194-201.

Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35:898-903.

Pedrinelli R, Penno G, Dell'Omo G, Bandinelli S, Giorgi D, Di Bello V. Micro-albuminuria and transcapillary albumin leakage in essential hypertension. Hypertension. 1999;34:491-5.

de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006;17:2100-5.

Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and non-cardiovascular mortality in general population. Circulation. 2002;106:1777-82.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National high blood pressure education program coordinating committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52.

Centers for Disease Control and Prevention (CDC). National Health And Nutrition Examination Survey: blood and urine collection. CDC, National Center for Health Statistics. Atlanta, GA, 2008.

Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39:445-59.

Roberto B, Steano B, Vito MC, Giorgio M. Prevalance of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron. 1992;61:94-7.

Mimran A, Ribstein J, Du Cailar G, Halimi JM. Albuminuria in normotensives and essential hypertension. J Diabetes Complications 1994;8:150-6.

Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalance and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study: Microalbuminuria: A Genoa Investigation on Complications. Hypertension. 1997; 30:1135-43.

Jalal S, Sofi FA, Alai MS, Siddqui MA, Bhat MA et al. Prevalance of Microalbuminuria in essential hypertension: A study of patients with mild to moderate hypertension. Indian J. Nephrol. 2001;11:6-11.

Wachtell K, Olsen MH, Dahlof B, Devereux RB, Kjeldsen SE, Nieminen MS, et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002;20:405-12.

Palatini P, Mormino P, Ballerini P, Mazzer A, Saladini F, Bortolazzi A, al. Microalbuminuria, renal function and development of sustained hypertension: a longitudinal study in the early state of hypertension. J. Hypertension. 2005;23:175-82.

Hitha B, Pappachan JM, Pillai HB, Sujathan P, Ramakrishna VD, Jayprakash K, et al. Micro-albuminuria in patients with essential hypertension and its relationship to Target organ damage. An Indian expereince (Kerala). Saudi journal of Kidney diseae and transplation. 2008;19:411-19.

Hillege HL, Janssen WMT, Bank AAA, Diercks GFH, Grobbbee DE, Crijns HJGM, et al. Micro-abuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. Journal of Internal Medicine. 2001;249:519-26.

Gould MM, Mohammed-Ali V, Goubet SA, Yudkin JS, Haines AP. Microalbuminuria: Associations with height and sex in non-diabetic subjects. BMJ. 1993;306:240-2.

Jacobein CV, Hans LH, Johannes GMB, Navis G, De Zeeuw D, De Jong PE. Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women (Prevend study). JA Soc Nephrol. 2003;14:1330-5

Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M et al. Microalbuminuria in the US population: Third National Health and Nutritional Examination Survey. Am J kidney Dis. 2002;39:445-59.

Ghai R, Singh NP, Verma AG, Bhatnagar MK, Kapoor P, Vashishta A. Microalbuminuria in non-insulin dependent diabetes and essential; hypertension: A marker of sever disease. JAPI. 1994;42:10-14.

Louise AD, Mennen I. Microalbuminuria and markers of the athero sclerosclerotic process: The DESIR study. Atherosclerosis 2001;154:163-9.

Pinto-Siestama SJ, Mulder J, Janssen WMT, Hillege HL, de Zeeuw D, Paul E. de Jong PE. Smoking is Related to Albuminuria and Abnormal Renal Function Nondiabetic Persons, Ann Intern Med. 2000;133:585-91.




How to Cite

Tagore, P. K., Gupta, A., Kumar, D., & Yadav, M. S. (2017). Correlates of microalbuminuria in hypertensive patients of a tertiary care teaching hospital of Central India. International Journal of Research in Medical Sciences, 4(8), 3402–3406.



Original Research Articles